- Display 15 Products per page
Published: November 25, 2024 | Price: $5,000.00 – $10,500.00
The U.S. IVD market is a cornerstone of global healthcare innovation—but it is also a market in transition In Vitro Diagnostics (IVD) in the United States: Comprehensive Market Overview 2024-2029, the fifth edition in Kalorama’s ongoing series, offers unparalleled access to insights on the trends and technologies that will define the industry's future. This report is essential for: Identifying market gaps and opportunities for product innovation. Gaining a competitive edge with strategic insights into the U.S. diagnostic landscape. Making informed...Published: August 29, 2024 | Price: $8,750.00 – $17,500.00
Kalorama Information's The Worldwide Market for In Vitro Diagnostic (IVD) Tests, now in its 17th edition, is the essential resource for anyone interested in or involved in the IVD industry. This comprehensive report provides reliable estimates, real-world forecasts from 2024 to 2029, and essential insights needed to understand the IVD market in its entirety. With every significant test category covered in detail, it's like having ten market research reports in one comprehensive volume. Key Features: Extensive Coverage: Detailed estimates and...Published: July 26, 2024 | Price: $5,000.00 – $10,500.00
Kalorama Information’s latest report, The Worldwide Market for Laboratory-Developed Tests (LDTs), 2023-2028, is now available for purchase. This comprehensive study delves into the dynamic landscape of LDTs, exploring both the services market and the market for test products sold to clinical laboratories. The Worldwide Market for Laboratory-Developed Tests includes comprehensive analysis of the effects of the FDA's new "Medical Devices: Laboratory Developed Tests" rule, passed in April 2024, which subjects LDTs to significantly greater regulatory oversight. Inclusion Criteria for LDTs: 2023-2024: LDTs...Published: April 30, 2024 | Price: $5,000.00 – $10,500.00
Authoritative market research on cell therapy, gene therapy, and RNA therapy analyzing markets by disease type Cell therapy and gene therapy represent a frontier in modern medicine, promising revolutionary treatments by treating the underlying genetic causes of disease and by genetically controlling the body's immune system. Recent years have seen an increase in new therapies and the pipeline indicates this trend will continue. A large range of therapeutic areas from oncology to cardiology have seen rapidly proliferating clinical trials. Cell...Published: December 29, 2023 | Price: $5,000.00 – $10,000.00
Liquid biopsies have emerged as a minimally invasive diagnostic tool, analyzing tumor-derived materials circulating in biological fluids to offer valuable information for cancer diagnosis, treatment, and monitoring. While tissue biopsies and imaging techniques remain standard in solid tumor diagnosis, liquid biopsies present an alternative or complementary approach, addressing some of the limitations and risks associated with traditional methods. Key applications of liquid biopsy testing in clinical oncology include: Early Detection and Diagnosis/Screening: Identifying cancer at an early stage. Alternative Testing...Published: December 19, 2023 | Price: $3,750.00 – $7,500.00
Recent years saw molecular diagnostics emerge as the fastest growing segment within the global in vitro diagnostics (IVD) market. The market was both boosted and challenged in unexpected ways by COVID-19. But where does the multi-billion-dollar molecular diagnostic market stand post pandemic? This new report by Kalorama Information, The World Market for Molecular Diagnostics, 12th Edition, reveals that post-pandemic the market remains ripe with opportunity, notably in the areas of infectious diseases, cancer, and transplant diagnostics. Global demand persists, with...Published: November 29, 2023 | Price: $5,000.00 – $10,000.00
In recent decades, the introduction of various new genetic technologies for research use and diagnostics has revolutionized many areas and opened new frontiers in healthcare. For example, next-generation sequencing (NGS) technologies have become widely used in genetic diseases, and have grown rapidly in oncology, due to the comprehensive insights they can provide at a relatively low cost. While older, PCR continues to be innovated and remains a central tool in molecular diagnostics laboratories of all kinds, and in situ hybridization...Published: August 24, 2023 | Price: $8,750.00 – $17,500.00
"The most trusted and essential report on the global IVD industry." For Two Decades, One Volume Has Offered Complete Coverage of the IVD Industry The 16th edition of Kalorama’s Worldwide Market for In Vitro Diagnostic Tests is a must have for anyone interested or involved in the IVD industry. Having a guide for the state of IVD and its future is a vital part of making well-informed decisions. The 16th edition of Kalorama’s Worldwide Market for In Vitro Diagnostic...Published: October 25, 2022 | Price: $5,000.00 – $10,000.00
Despite advances in cancer treatment, cancer continues to affect about 18.1 million people annually, generating a significant loss of life, financial burden and overall strain on the health industry. Worldwide between 35 and 40 million people are living with cancer and nearly 10 million people lose the battle annually. The most common cancers affecting the world population include lung, breast, colon/rectum, stomach, liver, prostate, cervical, esophageal, and bladder. Cancer deaths occur in about 50% of people who develop cancer in...Published: October 18, 2022 | Price: $5,000.00 – $10,000.00
The Asia Pacific (APAC) region is a fast-growing in vitro diagnostics (IVD) market, which is witnessing increasing focus by leading global players in the market. Southeast Asia has been identified as one of the key regions in APAC region offering significant opportunities for IVD companies. This report focuses on three IVD markets in Southeast Asia: Malaysia, Indonesia, and Singapore. These three countries together represent a fast-growing geographic region offering significant opportunity for IVD companies. The total population of these three...Published: October 6, 2022 | Price: $5,000.00 – $10,000.00
The U.S. market dominates the IVD industry AND remains the core geographical IVD market in the world. Yet this major multi-billion-dollar IVD market is in a state of flux, trying to manage a myriad of issues, all of which collide with a huge system that costs more than any other in the world. This latest report from Kalorama Information, United States Market for In Vitro Diagnostic (IVD) Tests, 4th Edition, discusses the trends shaping the present and future of the IVD...Published: January 1, 2022 | Price:
How Do You Plan to Keep Up With Developments in The Business of Cell and Gene Therapy in 2022? Consider Cell and Gene Therapy Business Outlook Each week brings news in Cell and Gene Therapy, from advances in clinical trials to product launches, from tools development to mergers and acquisitions. It can be a daunting task to keep up. Yet these developments are too fast-moving and significant for healthcare companies of any type to ignore. Now from Science and Medicine...Published: December 20, 2021 | Price: $3,000.00 – $6,000.00
Viral vectors are useful tools used by molecular biologists to delivery genetic material into cells. Kalorama Information’s Viral Vectors Market Analysis and Opportunities reveals that viral vectors comprise a rising market that is expected to continue to grow as usage increases and novel technologies enter the market. Viral vectors are the most effective means of gene transfer to modify specific cells or alter the expression of therapeutic genes. The choice of viral vector depends on the efficiency of transgene expression,...Published: September 29, 2021 | Price: $4,000.00 – $8,000.00
As an in vitro diagnostics (IVD) market, China trails only the populous, developed economy markets of the United States, western European countries, and Japan. The country and its healthcare system are confronted by challenges shared by less developed countries, but also burdens common among developed middle-income and affluent countries such as diabetes, cardiovascular disease, and diseases of aging. China as an IVD market opportunity is defined by its standing next to other populous countries with demonstrated economic promise for over...Published: June 7, 2021 | Price: $4,000.00 – $8,000.00
The U.S. market dominates the IVD industry AND remains the core geographical IVD market in the world. Yet this major multi-billion-dollar IVD market is in a state of flux, trying to manage a myriad of issues, all of which collide with a huge system that costs more than any other in the world. COVID-19 had a profound effect on the IVD diagnostic industry – some segments exploded and others languished. At this point in time, it is hard to predict...